27
Aug 2026
A new approach to care for people experiencing a mental health crisis, emphasising continuity and community, can reduce hospital admissions and improve satisfaction with care, finds a study led by a University College London (UCL) researcher.
27
Aug 2026
In people diagnosed with early-onset Alzheimer's disease, a biomarker tool that detects shrinkage of the brain's gray matter may predict how quickly someone may progress from mild cognitive impairment (MCI) to dementia, according to a new study published August 26, 2026, in Neurology, an official journal of the American Academy of Neurology.
27
Aug 2026
A researcher in Chicago remotely controls a miniaturized brain implant in Daejeon, Korea - over the internet. Korean researchers have developed a wireless device that can deliver drugs and light to precisely modulate targeted neurons from anywhere in the world.
27
Aug 2026
A British cardiologist and former president of the European Society of Cardiology (ESC) has been judged by the ESC to have committed severe misconduct after a Danish TV documentary reported that he had been involved in drawing up guidelines for the use of the heart drug ivabradine (Corlanor, Procoralan) while profiting from lucrative contracts with the drug's maker.
27
Aug 2026
Chronic health conditions such as diabetes, obesity, heart disease and metabolic liver disease have sharply increased in recent decades and are among the most urgent health challenges facing our society.
27
Aug 2026
Scientists have been hard at work for more than 20 years to instruct biological systems, such as E. coli cells, to produce proteins they don't naturally do.
27
Aug 2026
Mass General Brigham Neuroscience Institute researchers have found that a pattern of brain atrophy visible on MRI could help predict how quickly people with early-onset Alzheimer's disease progress from mild cognitive impairment to dementia.
27
Aug 2026
In a controlled crossover study of 51 recreationally active young men with low habitual caffeine intake, researchers tested whether 300 mg of caffeine taken about an hour before morning testing affected cognition, mood, temperature, appetite, and related outcomes, with reactive agility assessed in 27 participants. Caffeine did not improve cognitive or reactive agility performance or meaningfully alter mood, tiredness, appetite, or thermoregulation under the study conditions.
27
Aug 2026
Bedfont®, a world leader in breath analysis, has been recognized as one of Investec Direct Lending’s selected investments for 2025 following Keensight Capital’s majority investment in the company.
27
Aug 2026
A team of Weill Cornell Medicine investigators has developed a computer model that will help scientists more efficiently develop protein-destroying therapies, a newer type of treatment that is particularly promising for cancer.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
